Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.10B | 36.98B | 34.87B | 29.61B | 26.93B | 25.17B |
Gross Profit | 20.12B | 19.50B | 17.90B | 13.11B | 12.98B | 13.20B |
EBITDA | 7.76B | 6.69B | 5.72B | 1.62B | 2.59B | 274.00M |
Net Income | 3.96B | 3.64B | 5.30B | -1.78B | 122.00M | -4.72B |
Balance Sheet | ||||||
Total Assets | 59.10B | 51.34B | 51.16B | 45.40B | 50.80B | 46.66B |
Cash, Cash Equivalents and Short-Term Investments | 20.68B | 20.13B | 20.40B | 19.48B | 18.79B | 21.82B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 9.03B | 8.40B | 11.37B | 8.78B | 9.96B | 6.65B |
Stockholders Equity | 50.07B | 42.94B | 39.79B | 36.62B | 40.83B | 40.01B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.54B | 4.40B | 982.00M | -2.05B | -415.00M |
Operating Cash Flow | 0.00 | 3.73B | 5.51B | 3.07B | -52.00M | 1.85B |
Investing Cash Flow | 0.00 | -2.47B | -911.00M | -1.36B | -1.36B | -1.72B |
Financing Cash Flow | 0.00 | -1.13B | -3.47B | -1.12B | -1.12B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥48.50B | 6.01 | 5.23% | 15.52% | -4.85% | ||
74 Outperform | $594.04B | 10.97 | 19.86% | 4.43% | -8.81% | 14.09% | |
73 Outperform | ¥27.65B | 6.61 | 2.15% | 19.63% | 23.87% | ||
68 Neutral | ¥22.07B | 8.64 | 5.68% | 0.55% | -24.89% | ||
67 Neutral | ¥253.76B | 13.29 | 6.48% | 2.73% | 5.14% | -11.70% | |
61 Neutral | ¥7.29B | 29.13 | 3.70% | -5.98% | -53.43% | ||
44 Neutral | ¥76.48B | ― | -7.04% | 3.09% | -33.01% | -191.81% |